Description
The expression of GATA-3 has a strong association with estrogen receptor-alpha expression in breast cancer and evidence exists that GATA-3 may be used to predict response to hormonal therapy of breast cancer patients. GATA-3 has also been shown to be a novel marker for bladder cancer. In one study, GATA-3 stained 67% of 308 urothelial carcinomas but no prostate or renal carcinomas.
Specifications
| WEIGHT | N/A |
|---|---|
| DIMENSIONS | N/A |
| INTENDED USE | RUO |
| SPECIES REACTIVITY | Human |
| SOURCE | Mouse Monoclonal |
| CLONE | L50-823 |
| ISOTYPE | IgG1/kappa |
| ANTIGEN | Peptide between trans-activation and DNA-binding domains of GATA-3 |
| LOCALIZATION | Nuclear |
| POSITIVE CONTROL | Bladder cancer and breast cancer |
